Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

St. Jude Medical Inc Issues Q4 2013 Guidance In Line With Analysts' Estimates; Raises FY 2013 EPS Guidance; Issues FY 2013 Revenue Guidance In Line With Analysts' Estimates


Wednesday, 16 Oct 2013 07:30am EDT 

St. Jude Medical Inc announced that for fourth quarter of 2013, it expects revenue to be in the range of $1.315 billion to $1.395 billion and consolidated adjusted net earnings to be in the range of $0.95 to $0.97 per share. For fiscal 2013, it expects total revenue to be in the range of $5.394 billion to $5.474 billion and consolidated adjusted net earnings to be in the range of $3.72-$3.74. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $1.38 billion and EPS of $0.96 for fourth quarter of 2013; revenue of $5.44 billion and EPS of $3.72 for fiscal 2013. 

Company Quote

64.82
0.0 +0.00%
26 Aug 2014